RETA
Reata Pharmaceuticals Inc
Chief Innovation Officer Colin John Meyer sold $8.1M of Reata Pharmaceuticals Inc
Sold$8,145,224
$86.72Price
93,922Shares
−52%Stake
What RETA did after the filing
- The stock from Mon, Mar 6 close, $88.51
- +12.0%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 18 close.
Traded Thu, Mar 2. Filed Mon, Mar 6, 12:04 PM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.